BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 28727839)

  • 1. Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment.
    Potočnik N; Perše M; Cerar A; Injac R; Finderle Ž
    PLoS One; 2017; 12(7):e0181632. PubMed ID: 28727839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fullerenol C60(OH)24 prevents doxorubicin-induced acute cardiotoxicity in rats.
    Torres VM; Srdjenovic B; Jacevic V; Simic VD; Djordjevic A; Simplício AL
    Pharmacol Rep; 2010; 62(4):707-18. PubMed ID: 20885011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer.
    Injac R; Perse M; Cerne M; Potocnik N; Radic N; Govedarica B; Djordjevic A; Cerar A; Strukelj B
    Biomaterials; 2009 Feb; 30(6):1184-96. PubMed ID: 19046599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY; Najjar TA; Alashari M
    J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General oxidative stress during doxorubicin-induced cardiotoxicity in rats: absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid.
    Ghibu S; Delemasure S; Richard C; Guilland JC; Martin L; Gambert S; Rochette L; Vergely C
    Biochimie; 2012 Apr; 94(4):932-9. PubMed ID: 21396425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity.
    Galal A; El-Bakly WM; Al Haleem EN; El-Demerdash E
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):309-22. PubMed ID: 26676227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin-3-gallate pretreatment attenuates doxorubicin-induced cardiotoxicity in rats: A mechanistic study.
    Saeed NM; El-Naga RN; El-Bakly WM; Abdel-Rahman HM; Salah ElDin RA; El-Demerdash E
    Biochem Pharmacol; 2015 Jun; 95(3):145-55. PubMed ID: 25701654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Chemosensitizer Drug: Disulfiram Prevents Doxorubicin-Induced Cardiac Dysfunction and Oxidative Stress in Rats.
    Sonawane VK; Mahajan UB; Shinde SD; Chatterjee S; Chaudhari SS; Bhangale HA; Ojha S; Goyal SN; Kundu CN; Patil CR
    Cardiovasc Toxicol; 2018 Oct; 18(5):459-470. PubMed ID: 29779119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ameliorative Effect of Cardamom Aqueous Extract on Doxorubicin-Induced Cardiotoxicity in Rats.
    Abu Gazia M; El-Magd MA
    Cells Tissues Organs; 2018; 206(1-2):62-72. PubMed ID: 30716735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous electrocardiogram reveals differences in the short-term cardiotoxic response of Wistar-Kyoto and spontaneously hypertensive rats to doxorubicin.
    Hazari MS; Haykal-Coates N; Winsett DW; Costa DL; Farraj AK
    Toxicol Sci; 2009 Jul; 110(1):224-34. PubMed ID: 19407338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
    Abdel-Daim MM; Kilany OE; Khalifa HA; Ahmed AAM
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):745-753. PubMed ID: 28785995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gemfibrozil on cardiotoxicity induced by doxorubicin in male experimental rats.
    Haybar H; Goudarzi M; Mehrzadi S; Aminzadeh A; Khodayar MJ; Kalantar M; Fatemi I
    Biomed Pharmacother; 2019 Jan; 109():530-535. PubMed ID: 30551518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of curcumin nanoparticles against cardiotoxicity induced by doxorubicin in rat.
    Mohammed HS; Hosny EN; Khadrawy YA; Magdy M; Attia YS; Sayed OA; AbdElaal M
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165665. PubMed ID: 31918005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of multidrug resistance-associated protein 1 potentiates chronic doxorubicin-induced cardiac dysfunction in mice.
    Zhang W; Deng J; Sunkara M; Morris AJ; Wang C; St Clair D; Vore M
    J Pharmacol Exp Ther; 2015 Nov; 355(2):280-7. PubMed ID: 26354995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis.
    Shaker RA; Abboud SH; Assad HC; Hadi N
    BMC Pharmacol Toxicol; 2018 Jan; 19(1):3. PubMed ID: 29321061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity.
    Shoukry HS; Ammar HI; Rashed LA; Zikri MB; Shamaa AA; Abou Elfadl SG; Rub EA; Saravanan S; Dhingra S
    PLoS One; 2017; 12(7):e0181535. PubMed ID: 28727797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate dynamics in doxorubicin-induced cardiomyopathy.
    Lončar-Turukalo T; Vasić M; Tasić T; Mijatović G; Glumac S; Bajić D; Japunžić-Žigon N
    Physiol Meas; 2015 Apr; 36(4):727-39. PubMed ID: 25798626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotoxicity, nitric oxide level modulation and cardio-protective potential of Kalanchoe Integra Var. Crenata (Andr.) Cuf Leaves in murine models.
    Asiedu-Gyekye IJ; Arhin E; Arthur SA; N'guessan BB; Amponsah SK
    J Ethnopharmacol; 2022 Jan; 283():114640. PubMed ID: 34606947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats.
    Wan Y; He B; Zhu D; Wang L; Huang R; Zhu J; Wang C; Gao F
    Arch Biochem Biophys; 2021 Nov; 712():109050. PubMed ID: 34610336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of ivabradine on hemodynamic parameters and cardiotoxicity induced by doxorubicin treatment in rat.
    Colak MC; Parlakpinar H; Tasdemir S; Samdanci E; Kose E; Polat A; Sarihan E; Acet A
    Hum Exp Toxicol; 2012 Sep; 31(9):945-54. PubMed ID: 22354086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.